citric acid, anhydrous and fondaparinux

citric acid, anhydrous has been researched along with fondaparinux in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Liefeldt, L; Morgera, S; Neumayer, HH; Peters, H; Schneider, M; Slowinski, T1
Deitch, EA; Dong, W; Feinman, R; Feketeova, E; Lu, Q; Palange, D; Qin, X; Sheth, SU; Tiesi, G; Xu, D1
Jagielak, D; Kirwan, CJ; Kośka, A; Kowalik, MM; Lango, R; Lango-Maziarz, A; Szymanowicz, W1

Trials

1 trial(s) available for citric acid, anhydrous and fondaparinux

ArticleYear
Citrate anticoagulation protocol for slow extended hemodialysis with the Genius dialysis system in acute renal failure.
    The International journal of artificial organs, 2008, Volume: 31, Issue:1

    Topics: Acute Kidney Injury; Aged; Anticoagulants; Citric Acid; Feasibility Studies; Female; Fondaparinux; Hemodialysis Solutions; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Polysaccharides; Renal Dialysis; Treatment Outcome

2008

Other Studies

2 other study(ies) available for citric acid, anhydrous and fondaparinux

ArticleYear
Anticoagulants influence the in vitro activity and composition of shock lymph but not its in vivo activity.
    Shock (Augusta, Ga.), 2011, Volume: 36, Issue:2

    Topics: Animals; Anticoagulants; Cells, Cultured; Citric Acid; Endothelial Cells; Fondaparinux; Heparin; Lipase; Lymph; Male; Polysaccharides; Rats; Rats, Sprague-Dawley; Shock, Hemorrhagic

2011
Filter life span in postoperative cardiovascular surgery patients requiring continuous renal replacement therapy, using a postdilution regional citrate anticoagulation continuous hemofiltration circuit.
    Cardiology journal, 2022, Volume: 29, Issue:1

    Topics: Anticoagulants; Citric Acid; Continuous Renal Replacement Therapy; Fibrinolytic Agents; Fondaparinux; Hemofiltration; Heparin; Heparin, Low-Molecular-Weight; Humans; Longevity; Venous Thromboembolism

2022